Delivery Order SPE2DP18D0006-SPE2DP19F0321
Award Date 10/16/18
Potential Completion Date 11/5/18
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...
- This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
- This is a delivery order contract (SPE2DP19F0724) awarded by the U.S. Department of Defense (DoD) Medical Supply Chain to Glaxosmithkline, LLC for the provision of influenza virus vaccine. The $3,582 firm fixed price contract has a completion date of November 30, 2018 and does not utilize a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has provided a range of vaccines and antiviral medications to federal agencies through multiple indefinite delivery...
- This federal contract award, with ID SPE2DP18D0006|SPE2DP19F0455, was issued by the Defense Logistics Agency (DLA) to the prime contractor Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the delivery of influenza virus vaccine, with a ceiling value of $56,050. The contract type is Delivery Order with Firm Fixed Price pricing. The contract has no set-aside designation...
- This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC for the provision of influenza virus vaccines. The contract has a ceiling value of $2,405,037.60 and a period of performance ending on September 30, 2016. The contract was not set aside for any specific business category. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other products to U.S....
- This federal contract award, valued at $9,033,542.56, was issued by the Defense Department's Medical Supply Chain agency to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of influenza virus vaccines. The contract has a firm fixed price structure and an ultimate completion date of October 17, 2016. It is not designated as a set-aside contract. Glaxosmithkline has provided a range of pharmaceutical goods and services to various federal agencies, including vaccines, antiviral...
- This federal contract award with ID SPE2DP24D0005|SPE2DP24F3249 is for the delivery of influenza virus vaccines. The contract was awarded on March 14, 2024 to the prime contractor Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The contract has a ceiling value of $1,551,550.00 and is a firm fixed price delivery order contract with no set-aside designation. The...
- The U.S. government's Bureau of Administration, a civilian agency, awarded a firm fixed-price delivery order contract to GlaxoSmithKline, LLC for the provision of 2025-2026 influenza vaccines. The contract has a ceiling value of $667,575.00 and an ultimate completion date of October 9, 2025. This award is not set aside for any specific business type. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has been a critical supplier of vaccines, antivirals, and medical...
- <p>The Defense Logistics Agency Troop Support Medical awarded an $18.8 million firm fixed price delivery order contract to Glaxosmithkline, LLC for Influenza Virus Vaccines. The prime contractor Glaxosmithkline, LLC will perform the work at their facility located in Research Triangle Park, North Carolina. The period of performance is from August 31, 2022 through August 31, 2022. No applicable subcontractors were identified.</p>
- This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of flu vaccines. The $319,475 firm fixed-price delivery order contract has an October 15, 2017 completion date and was awarded on March 30, 2017. The contract did not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products to U.S. government agencies through federal contracts...